Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of investment in its GMP* manufacturing capabilities alongside strategic recruitment to the senior leadership team and the Board of Directors.
The £1.2m investment, has been led by Archangels, supported by Scottish Enterprise and BioCity Investments. The funding will enable BDD to invest in senior hires and significantly expand its current GMP capabilities to support product development, manufacture of clinical trial supplies and for rapid GMP manufacture of products to support its SWIFT adaptive clinical trials service.
Read more HERE.
